Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 9(1): 11598, 2019 08 12.
Artigo em Inglês | MEDLINE | ID: mdl-31406138

RESUMO

Prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing. Resulting fibrosis and portal hypertension, as a possible secondary event, may necessitate treatment. Overexpression of mouse renin in the transgenic rat model, TGR(mREN2)27, leads to spontaneous development of NAFLD. Therefore, we used TGR(mREN2)27 rats as a model of NAFLD where we hypothesized increased susceptibility and investigated fibrosis and portal hypertension and associated pathways. 12-week old TGR(mREN2)27 rats received either cholestatic (BDL) or toxic injury (CCl4 inhalation). Portal and systemic hemodynamic assessments were performed using microsphere technique with and without injection of the Janus-Kinase 2 (JAK2) inhibitor AG490 or the non-peptidic Ang(1-7) agonist, AVE0991. The extent of liver fibrosis was assessed in TGR(mREN2)27 and wild-type rats using standard techniques. Protein and mRNA levels of profibrotic, renin-angiotensin system components were assessed in liver and primary hepatic stellate cells (HSC) and hepatocytes. TGR(mREN2)27 rats developed spontaneous, but mild fibrosis and portal hypertension due to the activation of the JAK2/Arhgef1/ROCK pathway. AG490 decreased migration of HSC and portal pressure in isolated liver perfusions and in vivo. Fibrosis or portal hypertension after cholestatic (BDL) or toxic injury (CCl4) was not aggravated in TGR(mREN2)27 rats, probably due to decreased mouse renin expression in hepatocytes. Interestingly, portal hypertension was even blunted in TGR(mREN2)27 rats (with or without additional injury) by AVE0991. TGR(mREN2)27 rats are a suitable model of spontaneous liver fibrosis and portal hypertension but not with increased susceptibility to liver damage. After additional injury, the animals can be used to evaluate novel therapeutic strategies targeting Mas.


Assuntos
Hipertensão Portal/genética , Janus Quinase 2/metabolismo , Hepatopatia Gordurosa não Alcoólica/complicações , Proteínas Proto-Oncogênicas/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Animais , Hipertensão Portal/etiologia , Hipertensão Portal/metabolismo , Hepatopatia Gordurosa não Alcoólica/metabolismo , Proto-Oncogene Mas , RNA Mensageiro/metabolismo , Ratos , Ratos Transgênicos , Renina/metabolismo
2.
ACS Omega ; 2(2): 455-461, 2017 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-31457450

RESUMO

A microporous pH- and light-responsive membrane that enables remote control over its interfacial properties has been fabricated. pH-Responsiveness was imparted to a porous polypropylene film via grafting of poly(methacrylic acid) brushes from the substrate using argon-plasma-induced free-radical graft polymerization. Morphological changes as a function of grafting level were analyzed using atomic force microscopy. Conversion into a light-responsive membrane was performed via postpolymerization modification to covalently attach photochromic spiropyran moieties to the grafted polymer brushes. Reversible switches in wettability and permeability were determined upon changing from acidic to basic pH or upon alternating UV- and visible-light irradiation. Additionally, light-responsive membranes show a switch in color upon UV exposure.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...